youtube_live
Q2 2027 earnings • released • EPS beat +58.88% • Revenue beat +716.75%
See resultschevron_right
ROIV:NASDAQ
Roivant Sciences Ltd
$41.85
arrow_upward
+1.60%(+0.66) 1D
$41.32
arrow_downward
-1.27% (-0.53)bedtimeAfter hours
Closed: Nov 11, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ROIV...
Open
$41.47
High
$42.24
Low
$40.86
Mkt. cap
30.23B
Avg. vol.
7.19M
Volume
0.00
52-wk high
$42.50
52-wk low
$19.96
EPS
-$0.39
Beta
1.23
Shares outstanding
724.56M
No. of employees
721
Open
$41.47
High
$42.24
Low
$40.86
Mkt. cap
30.23B
Avg. vol.
7.19M
Volume
0.00
52-wk high
$42.50
52-wk low
$19.96
EPS
-$0.39
Beta
1.23
Shares outstanding
724.56M
No. of employees
721
News stories
From web sources and news partners
Yahoo Finance
·
11 hours ago
Roivant Sciences Ltd. (ROIV) Stock Forecasts
Seeking Alpha
·
12 hours ago
Don’t Fight The Momentum: Roivant Has Big Expectations, But Real Pipeline Momentum (ROIV)
Benzinga
·
1 day ago
Nvidia To $300? Here Are 10 Top Analyst Forecasts For Tuesday
GuruFocus
·
1 day ago
ROIV Maintained by HC Wainwright & Co. -- Price Target Raised to $48
Profile
Roivant Sciences Ltd. is an American multinational healthcare company focused on applying technology to drug development and building subsidiary life sciences and health technology companies. It was founded in 2014 by Vivek Ramaswamy and is currently headed by CEO Matt Gline. Roivant maintains its headquarters in New York City as well as major offices in the biotech hubs of Boston and Basel. Wikipedia
About Roivant Sciences Ltd
CEOMatt Gline
Employees721
FoundedApr 7, 2014
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteroivant.com